LS
Therapeutic Areas
Corline Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CHS™ Coated Stent | Neurovascular/Peripheral Vascular Disease | Commercial |
| CHS™ Coated Ablation Catheter | Cardiac Arrhythmia | Commercial |
| Renaparin® | Kidney Transplantation | Clinical Development |
| Cytoparin™ | Cell Therapy / Diabetes Type 1 | Research |
| CHC™ | Soft Tissue Repair | Research |
Leadership Team at Corline Biomedical
HN
Henrik Nittmar
Chief Executive Officer
ÅH
Åsa Holm
Chief Operating Officer
JM
Jawid Mirkhani
Director of Quality Assurance and Regulatory Affairs
AD
Adam Dahlberg
Chairman of the Board
GE
Gunilla Ekström
Non-Executive Board Member
HK
Henrik Krook
Non-Executive Board Member
MN
Magnus Nilsson
Non-Executive Board Member
RP
Rutger Ploeg
Scientific Advisor